Stock LNTH LANTHEUS HOLDINGS, INC.
Add to a list
To use this feature you must be a member
Log inSign up

All News Lantheus Holdings, Inc.

Equities

LNTH

US5165441032

Real-time Estimate Cboe BZX
Other stock markets
 18:57:03 03/05/2024 BST 		5-day change 1st Jan Change
75.14 USD -3.89% Intraday chart for Lantheus Holdings, Inc. +14.67% +21.26%
05:16pm Truist Raises Lantheus Holdings' PT to $94 From $82 After 'Solid' Q1 Beat, Keeps Buy Rating MT
05-02 Lantheus Shares Rise After Reporting Higher Q1 Adjusted Earnings, Revenue; 2024 Guidance Raised MT

All News

Search
See the results
Unlock all the news on all businesses: Never miss an investment opportunity again!
100% Free Registration
Truist Raises Lantheus Holdings' PT to $94 From $82 After 'Solid' Q1 Beat, Keeps Buy Rating
MT
Lantheus Shares Rise After Reporting Higher Q1 Adjusted Earnings, Revenue; 2024 Guidance Raised
MT
Transcript : Lantheus Holdings, Inc., Q1 2024 Earnings Call, May 02, 2024
Lantheus Holdings, Inc. Provides Revenue Guidance for the Second Quarter of Fiscal Year 2024
CI
Lantheus Holdings, Inc. Revises Revenue Guidance for the Full Fiscal Year 2024
CI
Lantheus Holdings: Q1 Earnings Snapshot
AQ
(LNTH) LANTHEUS HOLDINGS Sees Q2 EPS Range $1.81 - $1.86
MT
Earnings Flash (LNTH) LANTHEUS HOLDINGS Reports Q1 Revenue $370M
MT
Earnings Flash (LNTH) LANTHEUS HOLDINGS Reports Q1 EPS $1.69
MT
Lantheus Reports First Quarter 2024 Financial Results
GL
Lantheus Holdings, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024
CI
B. Riley Raises Price Target on Lantheus Holdings to $99 From $95, Keeps Buy Rating
MT
Lantheus to Host First Quarter 2024 Earnings Conference Call and Webcast on May 2, 2024, at 8:00 a.m. Eastern Time
AQ
Lantheus to Host First Quarter 2024 Earnings Conference Call and Webcast on May 2, 2024, at 8:00 a.m. Eastern Time
GL
Lantheus Holdings Insider Sold Shares Worth $262,005, According to a Recent SEC Filing
MT
Perspective Therapeutics, Inc. announced that it has received $87.409482 million in funding from Lantheus Holdings, Inc. and other investors
CI
Lantheus to Present at the Leerink Partners Global Biopharma Conference 2024
GL
Lantheus Holdings Says FDA Approves Expanded Use of Definity in Pediatric Patients
MT
Lantheus Announces the FDA Approval of DEFINITY® (Perflutren Lipid Microsphere) for Pediatric Patients
GL
Lantheus Holdings, Inc. Announces the FDA Approval of Definity (Perflutren Lipid Microsphere) for Pediatric Patients
CI
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. LNTH Stock
  4. News Lantheus Holdings, Inc.